(Total Views: 455)
Posted On: 10/29/2024 10:47:45 AM
Post# of 155808
Aren't you projecting on things not known?
$1b revenue?
I didn't make any revenue projections.
Only our shares becoming GSK valued.
" First, we are working on a pilot study of leronlimab in the treatment of patients with mild to moderate Alzheimer’s Disease. The study will evaluate a neuroradiology primary endpoint to determine efficacy. We are also grateful to the foundation that has tentatively agreed to fund this study but wishes to remain anonymous at this time."
If the foundation chooses to forward fund, it changes your this or that pickle.
My bet, they don't just pack up & go home if great, not good, great results.
$1b revenue?
I didn't make any revenue projections.
Only our shares becoming GSK valued.
" First, we are working on a pilot study of leronlimab in the treatment of patients with mild to moderate Alzheimer’s Disease. The study will evaluate a neuroradiology primary endpoint to determine efficacy. We are also grateful to the foundation that has tentatively agreed to fund this study but wishes to remain anonymous at this time."
If the foundation chooses to forward fund, it changes your this or that pickle.
My bet, they don't just pack up & go home if great, not good, great results.
(4)
(0)
